USP22 and metastatic malignant neoplasm in the lymph nodes: In summary, we reported that USP22 activated in a majority of clinical samples of OSCC and increased of USP22 expression exhibited a marked propensity toward highly malignant clinical behavior, lymph node metastasis, and poor survival after surgery.